Literature DB >> 2715991

IgG and IgA content of vaginal fluid during the menstrual cycle.

S J Usala1, F O Usala, R Haciski, J A Holt, G F Schumacher.   

Abstract

Immunoglobulin levels in cervicovaginal secretions during the menstrual cycle have not been well characterized biochemically. We determined the IgG and IgA concentrations in vaginal fluid obtained by patient self-sampling with an Ovu-Trac aspirator. Vaginal fluid IgG levels were less than 1-270 mg/dL. On the average the levels of IgG were relatively high after menstruation, declined during the ovulatory phase and remained relatively low during most of the luteal phase. The IgA levels were less than 10 mg/dL, and many samples contained IgA at our assay's lower limits of detection (microradial immunodiffusion). The preovulatory and luteal phase levels of IgG and IgA in vaginal fluid were generally lower than those reported for cervical mucus, but the ovulatory phase IgG and IgA composition was comparable between vaginal fluid and cervical mucus.

Entities:  

Keywords:  Biology; Cervical Mucus; Cervix; Clinical Research; Economic Factors; Endocrine System; Family Planning; Genitalia; Genitalia, Female; Gonadotropins; Gonadotropins, Pituitary; Hormones; Luteinizing Hormone; Menstrual Cycle; Menstruation; Ovulation; Physiology; Reproduction; Reproductive Control Agents; Research And Development; Research Methodology; Technology; Urogenital System; Uterus

Mesh:

Substances:

Year:  1989        PMID: 2715991

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  34 in total

Review 1.  Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors.

Authors:  B Dunbar; M Patel; J Fahey; C Wira
Journal:  Mol Cell Endocrinol       Date:  2012-01-25       Impact factor: 4.102

2.  Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion.

Authors:  Alex Chen; Scott A McKinley; Simi Wang; Feng Shi; Peter J Mucha; M Gregory Forest; Samuel K Lai
Journal:  Biophys J       Date:  2014-05-06       Impact factor: 4.033

3.  Interaction of menstrual cycle phase and sexual activity predicts mucosal and systemic humoral immunity in healthy women.

Authors:  Tierney K Lorenz; Gregory E Demas; Julia R Heiman
Journal:  Physiol Behav       Date:  2015-09-21

4.  Roles of glycoproteins and oligosaccharides found in human vaginal fluid in bacterial adherence.

Authors:  N Rajan; Q Cao; B E Anderson; D L Pruden; J Sensibar; J L Duncan; A J Schaeffer
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions.

Authors:  C Balmelli; R Roden; A Potts; J Schiller; P De Grandi; D Nardelli-Haefliger
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle.

Authors:  F X Lü; Z Ma; T Rourke; S Srinivasan; M McChesney; C J Miller
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis.

Authors:  D Provenzano; J F Alderete
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception.

Authors:  Gail F Shust; Sylvia Cho; Mimi Kim; Rebecca P Madan; Esmeralda M Guzman; Margaret Pollack; Julia Epstein; Hillel W Cohen; Marla J Keller; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2009-12-15       Impact factor: 3.886

Review 9.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

10.  Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus.

Authors:  Timothy Wessler; Alex Chen; Scott A McKinley; Richard Cone; Gregory Forest; Samuel K Lai
Journal:  ACS Infect Dis       Date:  2015-10-17       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.